# Drug Royalty IV, L.P. — Form D

Drug Royalty IV, L.P. of TORONTO, A6, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-11-14. Industry: Pooled Investment Fund.

## Offering

- Filed: 2018-11-14
- Form: D
- Accession: 0001315863-18-000867
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-325733

## Issuer

- Name: Drug Royalty IV, L.P.
- CIK: 0001756700
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 100 KING STREET WEST, TORONTO, A6, M5X 1B1
- Phone: 416.324.5714

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| N/A Drug Royalty IV GP, LLC | Executive Officer | Toronto, A6 |
| Behzad Khosrowshahi | Executive Officer | Toronto, A6 |
| Andrea Sotak | Executive Officer | Toronto, A6 |
| N/A DRI Capital, Inc. | Promoter | Toronto, A6 |
| N/A Drug Royalty IV GP, LLC | Promoter | Toronto, A6 |

## More

- [CIK 1756700 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1756700&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001315863-18-000867.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.